Site icon pharmaceutical daily

Global Musculoskeletal Partnering Deal Trends, Players and Financials 2014-2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Musculoskeletal Partnering 2014-2019: Deal Trends, Players and
Financials”
report has been added to ResearchAndMarkets.com’s
offering.

Global Musculoskeletal Partnering 2014 to 2019 provides the full
collection of Musculoskeletal disease deals signed between the world’s
pharmaceutical and biotechnology companies since 2014.

Most of the deals included within the report occur when a licensee
obtains a right or an option right to license a licensor’s product or
technology. More often these days these deals tend to be multi-component
including both a collaborative R&D and a commercialization of outcomes
element.

The report takes readers through the comprehensive Musculoskeletal
disease deal trends, key players and top deal values allowing the
understanding of how, why and under what terms companies are currently
entering Musculoskeletal deals.

The report presents financial deal terms values for Musculoskeletal
deals, where available listing by overall headline values, upfront
payments, milestones and royalties enabling readers to analyse and
benchmark the value of current deals.

The initial chapters of this report provide an orientation of
Musculoskeletal dealmaking trends.

In addition, a comprehensive appendix is provided with each report of
all Musculoskeletal partnering deals signed and announced since 2014.
The appendices are organized by company A-Z, stage of development at
signing, deal type (collaborative R&D, co-promotion, licensing etc) and
technology type. Each deal title links via Weblink to an online version
of the deal record and where available, the contract document, providing
easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the
trends and activities in Musculoskeletal partnering and dealmaking since
2014.

In conclusion, this report provides everything a prospective dealmaker
needs to know about partnering in the research, development and
commercialization of Musculoskeletal technologies and products.

Global Musculoskeletal Partnering 2014 to 2019 includes:

The report includes deals for the following indications: Arthritis,
Ankylosing spondylitis, Juvenile arthritis, Osteoarthritis, Psoriatic
arthriti, Rheumatoid arthritis, Bone fracture, Hip, Carpel tunnel
syndrome, Frozen shoulder, Gout, Knee, Meniscus damage, Muscular
dystrophy, Osteoporosis, Paget’s disease, Spinal muscular atrophy, Bone
pain, Back pain, Muscular pain, Stiffness, Weakness, plus other
musculoskeletal indications.

In Global Musculoskeletal Partnering 2014 to 2019, available
deals and contracts are listed by:

Analyzing actual contract agreements allows assessment of the
following:

For more information about this report visit https://www.researchandmarkets.com/r/l1if3z

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Musculoskeletal
Disorders Drugs

Exit mobile version